A dual GIP and GLP-1 receptor agonist. Supports appetite control and promotes safe, medically supervised weight loss.

An advanced solution for sustainable weight management and appetite regulation.

At La Belle MedSpa, we offer Mounjaro® (tirzepatide)—a breakthrough, FDA-approved injectable medication designed to support effective weight loss and long-term weight management. Originally developed for type 2 diabetes, Mounjaro is now widely used for medically supervised weight loss due to its ability to regulate appetite, stabilize blood sugar, and promote fat loss.

By Appointment Only

Schedule a Visit

By providing your mobile number, you consent to receive appointment-related SMS messages from La Belle Aesthetics, including confirmations, reminders, and updates. Message and data rates may apply. Message frequency varies. You may reply STOP at any time to unsubscribe. Your information is protected under HIPAA and will not be shared or sold.